Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO) announces the acquisition of an additional 12% of the equity capital of Arabian Medical Products Manufacturing Co. (ENAYAH), increasing its ownership from 51% to 63%.

Element List	Explanation
Introduction	Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO) has entered into a binding agreement to acquire an additional 12% stake in the capital of Arabian Medical Products Manufacturing Co. (ENAYAH), in which SPIMACO currently holds a 51% ownership. Upon completion of the acquisition, SPIMACO’s shareholding will increase to 63%, The acquisition will be carried out through the purchase of shares from Accendra Health, Inc.
Transaction Details	Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO) has entered into a binding agreement to acquire an additional 12% in the equity capital of Arabian Medical Products Manufacturing Co. (ENAYAH), in which SPIMACO currently holds a 51%. Upon completion of the acquisition, SPIMACO’s ownership will increase to 63%. The acquisition will be carried out through the purchase of shares from Accendra Health, Inc.
Transaction Amount	SAR 45 million (~USD 12 million).
Transaction Conditions	-Amendment of the company's Articles of Association. -Issuance of a new commercial registration by the Ministry of Commerce -Confirmation from the General Authority for Competition that there is no objection to the acquisition
Parties of the Transaction	Buyer: Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO). Target Company: Arabian Medical Products Manufacturing Co. (ENAYAH). Seller: Accendra Health, Inc.
Transaction Financing Method	From the company's internal resources
Date of Entering Into The Transaction	2026-06-11 Corresponding to 1447-12-25
Description of Activity of The Asset Subject of The Transaction	Arabian Medical Products Manufacturing Company (ENAYAH) ENAYAH Co. is a leading manufacturer of an extensive range of single-use healthcare products, including Surgical Gowns, Personal Protective Equipment, Surgical Customized Packs, Wound Care Accessories, and Sterilization Products. The company’s manufacturing facility is equipped with state-of-the-art technologies and houses one of the largest and most advanced sterilization facilities in the region. ENAYAH serves customers across Saudi Arabia, the GCC, the MENA region, and Europe.
Financial Statements for the Last Three Years of the Asset forming the Subject Matter of the Transaction	Arabian Medical Products Manufacturing Co. (ENAYAH)financial information: Revenue 2023: SAR 204,000,485 2024: SAR 203,504,191 2025: SAR 236,996,901 Profit for the year 2023: SAR 38,339,346 2024: SAR 43,550,135 2025: SAR 45,363,156
Transaction reasons	This step aligns with SPIMACO’s strategy to boost strategic investments by increasing its stake in Enayah. It supports business expansion and reinforces its role in the medical manufacturing sector, reflecting its commitment to enhancing production capabilities and partnering with leading national companies to advance the Kingdom’s pharmaceutical and medical industries.
Expected Impact of the Transaction on the Company and Its Operations	The financial impact of this acquisition is expected to be reflected in the financial statements starting from the second half of 2026.
Related Parties	-Mr. Faisal Abdullah AlFadley: Member of the Board of Directors of the Arabian Medical Products Manufacturing Company (ENAYAH), and serves as Executive Director of Investment and Subsidiaries at The Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) -Mr. Mohamd Ayed AlAssmari: Member of the Board of Directors of the Arabian Medical Products Manufacturing Company (ENAYAH), and serves as Chief Corporate Officer at The Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO)
Additional Information	N/A